Updating the Canadian Hemophilia Outcomes–Kids' Life Assessment

WFH Guidelines For The Management of Hemophilia, 3rd Edition, PDF, Bleeding

Late-breaking efanesoctocog alfa data presented at ISTH demonstrates highly effective bleed protection in children with severe haemophilia A with once-weekly dosing - SOBI + Sanofi - Medical Update Online

Health Canada approves Alhemo™, the first subcutaneous prophylactic treatment for people living with hemophilia B with inhibitors

Translation, cross-cultural adaptation and validation of the

Cureus, Management of Severe Hemophilia A: Low-Dose Prophylaxis vs. On-Demand Treatment

Factor XIII Deficiency: Practice Essentials, Background, Pathophysiology

Impact of prophylaxis on health‐related quality of life of boys

Updating the Canadian hemophilia outcomes-kids life assessment tool (CHO-KLAT Version2.0).

Frontiers The hemophilia quality of life scale: a systematic review

HIV in Canada, Surveillance Report to December 31, 2021